Umeå University
Umeå, SE-901 85, Sweden
NCT Number: NCT02776449
The main aim of this study is to determine the trans-laminal cribrosa pressure difference (TLCPD) for normal tension glaucoma (NTG) patients from the brain and the eye in supine, upright and minor head down tilt positions. It is also to investigate the venous drainage system in the same body positions.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
Umeå, SE-901 85, Sweden
The trans-lamina cribrosa pressure difference (TLCPD), i.e. the difference between the intraocular pressure (IOP) and the intracranial pressure (ICP) has been suggested as a pathophysiological component in glaucoma. The theory is that high TLCPD, either due to elevated IOP or reduced ICP, can cause glaucomatous damage.
Normal tension glaucoma (NTG) patients has been found to have a slightly reduced ICP when measured in horizontal position. However, in a previous study in healthy adult volunteers the investigators have measured TLCPD at supine, sitting and 9 degree head down tilt positions and found that the TLCPD was posture dependent, with the largest difference in the upright position. Since humans are upright approximately two thirds of the day, one can expect that TLCPD in a diurnal perspective is primarily influenced by the ICP in the upright position.
In this study the TLCPD in different positions in patients with NTG will therefore be measured.
The study will be carried out in three parts.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 day Single time point measurement
Difference between intraocular pressure (IOP) and intracranial pressure in different body positions
Time frame: 1 day Single time point measurement
Time frame: 1 day Single time point measurement
Umeå University
Other
Pathological Cerebral Venous Drainage System Giving Large Pressure Difference Between Brain and Eye at Upright Posture: a Possible Cause to Normal Tension Glaucoma.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06449352
Eye Diseases, Glaucoma
Austin, Texas, United States
View Trial DetailsNCT06266351
Eye Diseases, Glaucoma
Tucson, Arizona, United States
View Trial DetailsNCT01254149
Eye Diseases, Glaucoma
Omaha, Nebraska, United States
View Trial DetailsNCT04014933
Eye Diseases, Glaucoma
Zurich, Canton of Zurich, Switzerland
View Trial Details